Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Emerg Care ; 24(2): 71-4, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18277841

ABSTRACT

OBJECTIVE: The purpose of this study was to ascertain whether either parental recall or a state immunization registry was as accurate as the medical record in determining immunization status in the emergency department (ED). METHODS: A convenience sample of children younger than 5 years who presented to the ED between July 2004 and May 2005 were enrolled prospectively. After obtaining informed consent, parents were asked about their child's immunization status. All children then had their immunization data accessed in the Arizona State Immunization Information System. The information obtained from the state registry, as well as the information from the parental interview, was then compared with the information on the medical record obtained from the primary care physician (PCP). Data were analyzed using simple descriptive statistics. RESULTS: A total of 332 children were enrolled in the study. A total of 302 (91%) children enrolled were found in the state database, and 222 (74%) of these had a medical record available for comparison. The database agreed with the PCP record in 130 (59%) cases; parental report agreed with the PCP record in 149 (62%) cases. CONCLUSIONS: Although most children can be found in the state immunization registry, it seems to be similar in accuracy to parental recall of immunization status when each is compared with the medical record. This may have been due to either underreporting of immunizations from the community or a delay in updating the state database. At this time, neither parental recall nor the database would accurately determine a child's immunization status during an ED visit.


Subject(s)
Emergency Service, Hospital , Registries , Vaccination/statistics & numerical data , Arizona , Child, Preschool , Hospitals, Pediatric , Humans , Immunization Schedule , Infant , Infant, Newborn , Medical Records , Mental Recall , Parents , Predictive Value of Tests , Prospective Studies , Sampling Studies , Sensitivity and Specificity
2.
Pediatr Nephrol ; 23(3): 473-5, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17973124

ABSTRACT

Two patients with pheochromocytoma initially presented with behavioral symptoms similar to those seen with attention deficit hyperactivity disorder (ADHD): inability to concentrate, hyperactivity, and poor school performance. One patient was treated with dextroamphetamine/amphetamine for 4 months, at which time medication was discontinued when hypertension appeared. The second patient had hypertension when initially seen. All behavioral abnormalities resolved following tumor resection. Children with ADHD-like symptoms who present atypically at an older age or have other somatic signs and symptoms such as headaches and hypertension should undergo evaluation to rule out an organic etiology.


Subject(s)
Adrenal Gland Neoplasms/complications , Attention Deficit Disorder with Hyperactivity/etiology , Pheochromocytoma/complications , Adolescent , Adrenal Gland Neoplasms/diagnosis , Adrenal Gland Neoplasms/surgery , Child , Humans , Male , Pheochromocytoma/diagnosis , Pheochromocytoma/surgery
3.
Curr Opin Nephrol Hypertens ; 11(3): 331-5, 2002 May.
Article in English | MEDLINE | ID: mdl-11981264

ABSTRACT

Obesity, which has reached epidemic proportions in the United States and other western countries, may be complicated by hypertension, an increased incidence of renal cancer or proteinuria. Patients with obesity-associated proteinuria show focal glomerulosclerosis and glomerulomegaly on biopsy, usually have minimal clinical edema and relatively normal levels of serum albumin, cholesterol and blood pressure, and can progress to end-stage renal disease. Severe obesity may also be an additive risk factor in patients with preexisting nephropathy or reduced renal mass. The pathophysiology of obesity-associated proteinuria is unclear but may include hyperfiltration, increased renal venous pressure, glomerular hypertrophy, hyperlipidemia and increased synthesis of vasoactive and fibrogenic substances, including angiotensin II, insulin, leptin and transforming growth factor-beta1. These substances may individually or interactively affect glomerular hyperfiltration, mesangial cell hypertrophy and matrix production, and the production of collagen, fibronectin, transforming growth factor-beta and other fibrogenic mediators of change. Although angiotensin-converting enzyme inhibition has proven to have an impact, perhaps temporarily, on obesity-associated proteinuria in humans, weight reduction early in the course of the disease would appear the most important therapeutic approach.


Subject(s)
Kidney Diseases/etiology , Obesity/complications , Humans , Kidney Diseases/blood , Kidney Diseases/diagnosis , Kidney Diseases/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...